Patent Assignment
Reel/Frame 028381/0296
Assignment of Assignor's Interest
Recorded: 2012-06-15
Pages: 8
Assignors
BUKHALID, RAGHIDA
Executed: 2012-06-12
NIELSEN, ULRIK
Executed: 2012-06-12
WERNER, SHANNON
Executed: 2012-06-12
KEARNS, JEFFREY DAVID
Executed: 2012-06-13
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(2)
Methods of Treatment of Tumors Expressing Predominantly High Affinity Egfr Ligands or Tumors Expressing Predominantly Low Affinity Egfr Ligands with Monoclonal and Oglioclonal Anti-Egfr Antibodies
Methods and Kits for Predicting Tumor Responses to Antibodies Against Epidermal Growth Factor Receptor (Egfr) and Uses Thereof
Application:
61/493,252 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.